enVVeno Medical (NVNO) vs Trinity Biotech (TRIB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
enVVeno Medical is the larger company by market cap ($5.7 million vs $4.9 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | NVNO | TRIB |
|---|---|---|
| Share price | $8.18 | $6.04 |
| Market cap | $5.68M | $4.91M |
| 1-day change | -2.68% | -10.91% |
| EPS (TTM) | $-24.99 | $-60.00 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $30.80 | $52.50 |
| 52-week low | $7.01 | $5.01 |
| Distance from 52-week high | -73.46% | -88.50% |
| Analyst consensus | none | — |
| Avg. price target upside | +266.97% | — |
| Average volume | 23.71K | 21.66K |
| Shares outstanding | 694.83K | 813.13K |
| Employees | 33 | 287 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About enVVeno Medical
NVNO stock →enVVeno Medical Corporation, a medical device company, focuses on the development of bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous disease in the United States. The company's lead product is the VenoValve, a surgical replacement venous valve for the treatment of venous chronic venous insufficiency.
Health Care · Medical/Dental Instruments · 33 employees
About Trinity Biotech
TRIB stock →Trinity Biotech plc, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic measurement of haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances · 287 employees
NVNO vs TRIB FAQ
Which is bigger, enVVeno Medical or Trinity Biotech?
enVVeno Medical (NVNO) is larger, with a market capitalization of $5.68M compared with $4.91M for Trinity Biotech (TRIB).
Are enVVeno Medical and Trinity Biotech in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for enVVeno Medical and Biotechnology: In Vitro & In Vivo Diagnostic Substances for Trinity Biotech.